ENTITY
Hua Medicine

Hua Medicine (2552 HK)

32
Analysis
Health Care • China
Hua Medicine is an innovative drug development and commercialization company focused on novel therapies for patients with unmet medical needs, particularly in diabetes care. Its cornerstone product is HuaTangNing (dorzagliatin tablets), a first-in-class oral drug for the treatment of Type 2 diabetes. The company was founded in 2011 and is headquartered in Shanghai, China.
more
Company Presentation • 17 Mar 2020 09:30

H2 2019

Company Presentation • 21 Aug 2026 11:30

H1 2026

Company Presentation • 19 May 2020 20:30

UBS Virtual Global Healthcare Conference

Company Presentation • 29 Aug 2025 08:00

H1 2025

Company Presentation • 28 Mar 2025 08:30

H2 2024

x